Trial Details

COMPLETED
Basic Information
Clinical ID c478
Identifier NCT00267306
Trial Title Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Severe Ulcerative Colitis
Interventions DRUG: Visilizumab
Participant Information
Sponsor Facet Biotech
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2025-01-04
Primary Completion Date 2025-12-06
Completion Date 2025-12-06